Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,740,239,592
-
Total 13F shares
-
1,304,304,663
-
Share change
-
-16,040,362
-
Total reported value
-
$119,298,426,006
-
Put/Call ratio
-
103%
-
Price per share
-
$91.43
-
Number of holders
-
2,237
-
Value change
-
-$1,426,498,089
-
Number of buys
-
1,056
-
Number of sells
-
921
Institutional Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q2 2020
As of 30 Jun 2020,
ABBOTT LABORATORIES - Common Stock (ABT) was held by
2,237 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,304,304,663 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Capital Research Global Investors, STATE STREET CORP, Capital International Investors, WELLINGTON MANAGEMENT GROUP LLP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, and MORGAN STANLEY.
This page lists
2,238
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.